-
Buprenorphine, sold
under the
brand name
Subutex among others, is an
opioid used to
treat opioid use disorder,
acute pain, and
chronic pain. It can be...
-
Buprenorphine/naloxone, sold
under the
brand name
Suboxone among others, is a fixed-dose
combination medication that
includes buprenorphine and naloxone...
-
Buprenorphine/samidorphan (developmental code name ALKS-5461) is a
combination formulation of
buprenorphine and
samidorphan which is
under development...
-
Buprenorphine/naltrexone is an
experimental combination drug
formulation of
buprenorphine, a μ-opioid
receptor (MOR) weak
partial agonist and κ-opioid...
- "
Buprenorphine". www.samhsa.gov.
Retrieved 10
November 2022.
Yokell MA,
Zaller ND,
Green TC, Rich JD (March 2011). "
Buprenorphine and
buprenorphine/naloxone...
-
Buprenorphine-3-glucuronide (B3G) is a
major active metabolite of the
opioid modulator buprenorphine. It has
affinity for the μ-opioid
receptor (Ki = 4...
- and
decreases heroin use
compared to a placebo.
Unlike methadone and
buprenorphine, it is not a
controlled medication. It may
decrease cravings for opioids...
-
Disorder (MOUD) is used to
describe medication including methadone and
buprenorphine,
which are used to
treat patients with OUD.
Other terms that appear...
- R (February 2007). "The
Buprenorphine Effect on Depression" (PDF). naabt.org.
National Alliance of
Advocates for
Buprenorphine Treatment.
Retrieved 19...
-
combination of
buprenorphine and
naloxone is
injected by a
regular user of
buprenorphine or
buprenorphine/naloxone, then the
buprenorphine would still produce...
